NCT05403723 2026-02-19Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCUniversity of Maryland, BaltimorePhase 1 Suspended50 enrolled
NCT06692452 2026-01-07Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Suspended24 enrolled
NCT05955261 2025-12-09A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid LeukemiaSt. Jude Children's Research HospitalPhase 2 Suspended70 enrolled